A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)
Clinical trial NCT02371967 · COMPLETED
Trial details
- NCT number
- NCT02371967
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-08
- Primary completion
- 2020-08-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.